A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers

The causative factors for the recent increase in early-onset colorectal cancer (EO-CRC) incidence are unknown. We sought to determine if early-onset disease is clinically or genomically distinct from average-onset colorectal cancer (AO-CRC). Clinical, histopathologic, and genomic characteristics of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JNCI : Journal of the National Cancer Institute 2021-11, Vol.113 (12), p.1683-1692
Hauptverfasser: Cercek, Andrea, Chatila, Walid K, Yaeger, Rona, Walch, Henry, Fernandes, Gustavo Dos Santos, Krishnan, Asha, Palmaira, Lerie, Maio, Anna, Kemel, Yelena, Srinivasan, Preethi, Bandlamudi, Chaitanya, Salo-Mullen, Erin, Tejada, Prince R, Belanfanti, Kimeisha, Galle, Jesse, Joseph, Vijai, Segal, Neil, Varghese, Anna, Reidy-Lagunes, Diane, Shia, Jinru, Vakiani, Efsevia, Mondaca, Sebastian, Mendelsohn, Robin, Lumish, Melissa A, Steinruecke, Felix, Kemeny, Nancy, Connell, Louise, Ganesh, Karuna, Markowitz, Arnold, Nash, Garrett, Guillem, Jose, Smith, J Joshua, Paty, Phillip B, Zhang, Liying, Mandelker, Diana, Birsoy, Ozge, Robson, Mark, Offit, Kenneth, Taylor, Barry, Berger, Michael, Solit, David, Weiser, Martin, Saltz, Leonard B, Aguilar, Julio Garcia, Schultz, Nikolaus, Diaz, Luis A, Stadler, Zsofia K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The causative factors for the recent increase in early-onset colorectal cancer (EO-CRC) incidence are unknown. We sought to determine if early-onset disease is clinically or genomically distinct from average-onset colorectal cancer (AO-CRC). Clinical, histopathologic, and genomic characteristics of EO-CRC patients (2014-2019), divided into age 35 years and younger and 36-49 years at diagnosis, were compared with AO-CRC (50 years and older). Patients with mismatch repair deficient tumors, CRC-related hereditary syndromes, and inflammatory bowel disease were excluded from all but the germline analysis. All statistical tests were 2-sided. In total, 759 patients with EO-CRC (35 years, n = 151; 36-49 years, n = 608) and AO-CRC (n = 687) were included. Left-sided tumors (35 years and younger = 80.8%; 36-49 years = 83.7%; AO = 63.9%; P 
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/djab124